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Abstract
During annual physical examinations, a primary-care physician listens to the heart
using a stethoscope to assess the condition of the heart muscle and valves. This
process, termed cardiac auscultation, is the primary means of diagnosing cardiac dis-
orders, the most common of which is Mitral Valve Prolapse (MVP). Yet, the practice
of auscultation is highly fallible with reports of more than 80% of MVP referrals to
cardiologists being unnecessary.
The overall goal is to develop an inexpensive, easy-to-deploy software application
to detect Mitral Valve Prolapse. Using an electronic stethoscope, audio and EKG
data were simultaneously recorded for 51 subjects. The data was then manipulated
and a prototypical beat, representative of an individual's pathology, was generated
based on Z. Syed's work1 .
This thesis presents a method for analyzing this prototypical beat. We extract 31
features from the prototypical beat, focusing on systolic activity. We then use the
feature set as input to a radial-kernel support vector machine (SVM), which gives a
binary classification of the subject as an MVP or non-MVP patient. We support our
decision with a visual time-frequency decomposition of a patient's prototypical beat
and relevant features.
Of the 51 subjects in our test set, we report three false negatives and five false
positives. We achieve 82% sensitivity while reducing the false-positive rate to 15%.
Thesis Supervisor: Dorothy W. Curtis
Title: Research Scientist, Computer Science & Artificial Intelligence Laboratory
'Zeeshan Syed (MIT '03) developed an algorithm to generate a prototypical beat as part of his
M.Eng. thesis work.
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Chapter 1
Introduction
During annual physical examinations, a primary-care physician listens to the heart
using a stethoscope to assess the condition of the heart muscle and valves. This
process, termed cardiac auscultation, is the primary means of diagnosing cardiac
disorders, the most common of which is Mitral Valve Prolapse (MVP). Mitral Valve
Prolapse is considered to affect up to 5% of the general population [10]. However, the
practice of auscultation is highly fallible with a substantial number of unnecessary
referrals to cardiologists. This is because detecting relevant symptoms and forming a
diagnosis based on heart sounds is a skill that can take years to acquire and refine.
The human heart produces sounds having low frequency (20-1000 Hz), large dy-
namic range and rapidly changing content. And, the human ear can often be fooled
by many of the subtleties of heart sounds. Part of the difficulty stems from the fact
that heart sounds are often separated from one another by less than 30 ms [17]. Com-
pounding the matter, the energy in the most relevant part of the signal is often far
less than (at times, less than a thousandth of) the total energy. The analysis of heart
sounds consequently remains a challenge for many physicians.
Improved cardiac auscultation could have a significant impact on the quality and
cost of medical care. The contemporary "gold standard" tests are expensive and often
unnecessary. As many as 87% of patients referred to cardiologists have only benign
heart murmurs [17]. The resultant inefficiency is substantial, as the cost of a visit
to a cardiologist (including associated echocardiography) runs anywhere from $300
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to $1000 in the United States [17]. In addition, there are also many forms of heart
disease that remain asymptomatic and, therefore, undetected until they eventually
deteriorate into serious medical disorders.
The goal of the auscultation section of the Patient Centric Network project at
MIT's Computer Science and Artificial Intelligence Laboratory is the design, imple-
mentation and evaluation of an inexpensive-to-deploy and easy-to-use software appli-
cation system that can be used, in the office of a primary-care physician, to determine
whether further examination, by means of an echocardiogram and consultations with
cardiac specialists, is appropriate. The system aims to make a recommendation and
support its decision with visual diagnostic aids, such as images of a prototypical
heartbeat and relevant features. In addition, the system should present its recom-
mendations in a transparent manner that can be validated in light of physiological
knowledge. By doing so, the group hopes to demystify auscultation, and thereby
improve the quality of its practice.
1.1 Problem Statement
The research presented here is part of an ongoing project of the aforementioned
Patient Centric Network group. In particular, our work builds heavily upon the
thesis work of Zeeshan Syed, who developed a preliminary system to detect Mitral
Valve Prolapse through automated auscultation [22]. This project aims to extend
and improve Syed's work in this area.
Several aspects of Syed's technical approach to the problem of automated aus-
cultation are preserved in this work. Specifically, Syed's concept of a prototypical
beat, generated from raw recordings of audio and EKG signals, as representative of a
patient's pathology is fundamental to our work. This project seeks to gain a better
understanding of the prototypical beat, and thereby fully leverage the information
present in it. We do so by computing a feature set, characterizing different diagnostic
features present in the prototypical beat. Using this feature set, we employ a support
vector machine as a binary classifier in a new multi-dimensional feature space [11].
14
Finally, we extend Syed's library of visual aids, used to support the findings of the
system, to include these new features in the display of the prototypical beat.
15
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Chapter 2
Background
In this section, we offer a brief review of relevant cardiac terminology1 , followed by
a discussion of heart murmurs with particular emphasis on murmurs associated with
Mitral Valve Prolapse.
2.1 Review of Cardiac Functions
2.1.1 Heart Physiology
The heart consists of four chambers: the right and left atria and the right and left
ventricles [4]. The two atria act as collecting reservoirs for blood returning to the
heart while the two ventricles act as pumps to eject the blood to the body. De-
oxygenated blood returns to the heart via the major veins (superior and inferior vena
cava), enters the right atrium, passes into the right ventricle, and from there is ejected
to the pulmonary artery on the way to the lungs. Oxygenated blood returning from
the lungs enters the left atrium via the pulmonary vein, passes into the left ventricle,
and is then ejected to the aorta.
In addition, the heart has four major valves, which ensure the unidirectional flow of
blood throughout the system. The atria are separated from their respective ventricles
by the atrioventricular (AV) valves. More precisely, the tricuspid valve separates the
'This information comes from medical literature and is the widely aceepted view of cardiac
anatomy and functions [4, 13, 16].
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Figure 2-1: Chambers and Valves of the Heart
right atrium from the right ventricle while the mitral valve separates the left chambers
of the heart. Two more valves, the semilunar (SL) valves, close off the ventricles from
the arteries to which they lead. The pulmonary valve separates the right ventricle
from the pulmonary artery and the aortic valve separates the left ventricle from the
aorta. Collectively, these four valves prevent the back-flow of blood in the heart.
2.1.2 Cardiac Cycle
The cardiac cycle refers to the sequence of events in the heart from the beginning
of one heart-beat to the beginning of the next. Physiologically, an electrical impulse
originates at the Sinoatrial node (SA node) and is conducted through the heart mus-
cle, causing the atria to contract and then the ventricles, and, finally, causing the
unidirectional flow of blood throughout the human body.
The cardiac cycle is comprised of two phases: systole and diastole. Systole is
surrounded by two major heart sounds, commonly referred to as a "lub-dub" pair.
The first heart sound (Si) corresponds to the shutting of the atrioventricular (AV)
valves (i.e. mitral and tricuspid valves). The second heart sound (S2) indicates the
18
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Figure 2-2: Typical EKG Waveform
closing of the aortic and pulmonary valves.
The electrical activity which causes the heart's chambers to contract can be
recorded and expressed by an electrocardiogram (EKG). In analyzing the heart's
electrical signal (EKG), the QRS complex reflects depolarization of the ventricular
membrane, which directly causes ventricular contraction. The contraction of the ven-
tricles then causes a rapid increase in intra-ventricular pressure, causing the AV valves
to shut. As mentioned, closure of these valves results in the first heart sound (Si).
Furthermore, in the EKG signal, the T-wave indicates repolarization of the ventri-
cles, causing them to relax. The timing of the T-wave in the cardiac cycle corresponds
to a decrease in intra-ventricular pressure due to the outflow of blood. When the ven-
tricular ejection rate reaches zero, the aortic and pulmonary valves shut, causing the
second heart sound (S2). Thus, we conclude that S2 occurs in a small time window
following the T-wave in the corresponding EKG signal.
It is important to note that both S1 and S2 correspond to the shutting of two
separate pairs of valves. Thus, both S1 and S2 are not instantaneous events, but
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rather they persist for some small duration of the cardiac cycle. The first heart sound
with its mitral and tricuspid components, lasts for an average period of 100-200 ms,
its frequency components lie in the range 10-200 Hz [8]. As for S2, the closure of
the aortic valve and the pulmonary valve can often be separated by 20 ms and each
component is approximately 10-30 ms in duration. The entire second heart sound
contains frequencies in the range 10-400 Hz. The second heart sound usually has
higher frequency content than the first heart sound because of the lesser mass of
blood present in the cardiac chamber at the end of systole. The first and second
heart sounds are separated by approximately 300-400 ms [8].
In our work, we define systole to be from the R-wave in the QRS complex, as
found in the EKG signal, to the peak of the second heart sound (S2) in the audio
signal.
2.2 Mitral Valve Prolapse
Mitral Valve Prolapse (MVP) is the most common condition affecting the valves of
the heart [10]. The mitral valve is composed of two triangular flaps, which billow up
to close off the channel between the chambers on the left side of the heart. Mitral
Valve Prolapse refers to a malfunction where the two leaflets bulge (or prolapse) into
the left atrium, preventing the mitral valve from closing properly. As a result, rather
than a unidirectional flow of blood, some blood may leak back into the atrium. Mitral
Valve Prolapse is thought to affect 2-5% of the adult population in the United States.
In spite of its prevalence, many people with MVP never exhibit signs or symptoms
of the condition. When symptoms do occur, they can vary widely. More common
signs of MVP include an irregular heartbeat (arrhythmia), dizziness, difficulty breath-
ing, fatigue and anxiety [5]. However, no unique set of physical symptoms exists to
diagnosis Mitral Valve Prolapse. Most frequently, a primary-care physician detects
MVP during a routine examination of the heart using a stethoscope, a procedure
termed auscultation. If an individual suffers from MVP, abnormal heart sounds,
including a characteristic clicking noise or murmur, will be often be present. To con-
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firm the diagnosis, a specialist often conducts an echocardiogram. An echocardiogram
uses high-frequency ultrasound waves to create a visual image of the heart, including
the mitral valve and the flow of blood through it. By analyzing the sonar image,
a cardiologist can, make a more definitive diagnosis. In some cases, further tests
may be necessary, including chest X-rays, color Doppler ultrasound and/or cardiac
catheterization. However, echocardiograms are widely considered the "gold-standard"
in diagnosing MVP.
Complications associated with MVP are rare. Still in instances of severe regur-
gitation, there is an increased risk of developing bacterial endocarditis, an infection
affecting the mitral valve and/or the heart's lining. Consequently, many doctors pre-
scribe prophylactic antibiotics to individuals with moderate to severe MVP. In more
serious cases, surgery to repair or replace the faulty valve is recommended to pre-
vent complications associated with further deterioration. Yet, for the vast majority
of people with MVP, no special treatment is necessary and simple monitoring of the
condition is sufficient [5].
2.3 Heart Murmurs
Heart murmurs are irregular sounds produced by the heart, often described as a
swishing or whistling noise. Murmurs may be innocent or indicative of a more serious
heart pathology. Benign murmurs, also called functional murmurs, are a result of
turbulent blood flow, causing the walls of the heart to vibrate. Murmurs may also
be caused by malfunction or malformations of the heart valves. Such a condition
causes a regurgitation of blood (backwards across the valve), which accounts for the
murmur.
Heart murmurs are characterized according to intensity (loudness), frequency
(pitch), configuration (shape), quality, duration, direction of radiation, and timing
in the cardiac cycle [2]. Establishing these features is the basis for drawing diagnostic
conclusions about the murmur. Classification of murmurs is critical in distinguish-
ing innocent murmurs from pathological murmurs, as well as identifying the various
21
pathological conditions.
2.3.1 Murmurs caused by Mitral Valve Prolapse
Murmurs caused by Mitral Valve Prolapse have a unique acoustic signature. Follow-
ing a normal S1 and a brief period of quiet, the valve suddenly prolapses, at times
producing an audible, mid-systolic click. This click is sufficient to diagnose MVP,
even without the presence of a subsequent murmur. Yet, often times, the click is
succeeded by a crescendo-decrescendo murmur, which peaks at some point between
mid to late systole [23]. Specifically, the murmur is a result of the turbulent backflow
of blood across the prolapsed mitral valve. As the left ventricle contracts, pressure
increases in the chamber. Eventually, the pressure forces blood back into the left
atrium. The flow of blood through a small orifice, between the faulty flaps of the mi-
tral valve, produces a high frequency murmur spanning 200-1000 Hz. In the case of
significant mitral regurgitation, MVP may reveal a holosystolic murmur. The mitral
valve, in such cases, is so compromised that it permits the backflow of blood over the
entire systolic period, in contrast to the more typical late-systolic murmur.
The murmur is usually most audible at the apex of the heart, between the fifth
and sixth intercostal spaces. This area is known as the mitral region of the anterior
chest during auscultation and, as such, is particularly relevant to diagnosing MVP. In
addition to the location at which to listen for the murmur, physical maneuvering of
the patient is significant. Physical maneuvers may enhance the quality of the murmur.
In particular, dynamic maneuvers, including Valsalva and prompt standing, decrease
left ventricular volume. And in doing so, they cause earlier prolapse of the mitral
valve and a longer associated murmur. Having the patient in supine position (i.e.
lying on his/her back) produces similar results to the Valsalva maneuvers [2].
Other possible indicators of Mitral Valve Prolapse include a quiet S1 and a widely
split S2 [15]. As previously noted, S1 corresponds to closure of the AV valves, with
the mitral valve dominating. Since valve closure is faulty in individuals with MVP,
S1 may be noticeable quieter. Also in cases of severe regurgitation, the decreased
resistance to left ventricular ejection may cause the aortic valve to close prematurely.
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Recalling that S2 indicates shutting of the aortic and pulmonary valves, early closure
of the aortic valve results in a widely split S2 sound.
This information related to the timing, frequency, and location of heart murmurs
is the basis for our approach to diagnosing cardiac pathologies using acoustic signals.
23
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Chapter 3
Prototypical Beat Construction
As discussed in Section 2.3.1, Mitral Valve Prolapse can be identified by examining
the latter half of systole for abnormal cardiac activity. In order to make a diagnosis,
the MAAS algorithm, developed by Zeeshan Syed, creates a prototypical beat [22].
A prototypical beat will lose some information related to the variations among beats
but has the benefit of suppressing some noise.
This section reviews the construction of a prototypical beat from the acoustic and
EKG data. The progression from raw data to a prototypical beat can be seen in
the following subsections. First, the audio signal is segmented into individual beats
using the synchronously-recorded EKG signal. Next, a time-frequency decomposition
is applied to the individual beats, separating each beat into 16 frequency bands. A
prototypical beat is then constructed from the separate beats using median filtering.
Finally, the 16 frequency bands of the prototypical beat are aggregated into 4 bands
to be further analyzed.
3.1 Beat Segmentation
The recorded audio and EKG data are first processed to extract beats considered
to contain the most diagnostic information [22]. The program begins by reading in
the raw audio and EKG signals, sampled at rate of 44,100 Hz, and produces indexed
vectors. The next task is to segment the audio signal into individual beats. This is
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Figure 3-1: Simultaneously Recorded Audio and EKG Signals. Courtesy of Z. Syed.
done by using the synchronous EKG signal to find the indices associated with the
onset of the QRS complex and the T-wave. The R-wave of the QRS complex indicates
the onset of electrical activity associated with a given beat. These indices are used
as preliminary reference points. Using a window about the T wave indices, a search
is conducted to locate the peak of the S2 sound of each beat in the audio data. Thus,
we have indices of the R-wave, T-wave and S2 peak for each beat.
Having segmented the audio signal into individual beats, the algorithm now selects
beats for analysis based on a "Length-biased Admission of Noise-free Beats" criterion.
That is, the program omits those beats considered to be too noisy for useful analysis
while it is biased to admit beats of suitable length [22].
3.2 Time-Frequency Decomposition
As mentioned in Section 2.3.1, the acoustic signature of Mitral Valve Prolapse consists
of energy at higher frequencies during the latter half of systole. Therefore, both the
frequency composition and the timing of cardiac events are important in diagnosis,
so a time-frequency decomposition is applied to the audio data.
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To precisely analyze the frequencies in the selected beats, the program uses a
filter bank that analyzes each heart-beat using a series of sharp frequency filters. As
a special note, the filters must have narrow transition bands so minimal blurring of
information occurs between adjacent frequency bands. This proves to be critical to
the solution because the magnitude of lower frequency energy is often far greater than
that of higher frequencies; so trends at higher frequencies will be masked otherwise
[22].
In all, the filter bank consists of sixteen bans, each spanning a 50 Hz interval
from 50 to 850 Hz. By opting to use such a filter bank, the algorithm maintains high
fidelity to the timing of cardiac events while revealing trends at different frequencies.
Now, a time-frequency analysis provides us with the frequency components in sixteen
bands for each selected beat.
3.3 Median Filtering
In order to observe trends persisting amongst the majority of the beats, a mechanism
to merge information from multiple beats to create a single representative heart-beat
for the patient is developed. In other words, the program assimilates information from
the selected beats to generate the time-frequency decomposition of a hypothetical
"typical" beat for the patient. Such a time-frequency decomposition will be organized
into the same sixteen frequency bands as mentioned in Section 3.1.
The prototypical beat is constructed as follows. The algorithm begins by taking
the absolute value of the audio data and lining up selected beats in time for each of the
sixteen frequency bands. Next, for each of the frequency bands, it finds the median
four amplitudes of the beats at all time instances. The program then computes the
means of the four median values at every time instance for each of the bands and
makes them the associated values of the prototypical beat.
Although the construction of the prototypical heart-beat loses some variations
between beats, it does not result in a significant loss of relevant information. Pa-
tients suffering from Mitral Valve Prolapse exhibit pathological signs in the majority
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of recorded beats. Therefore, the median values are believed to correspond to four
beats, all possessing the MVP acoustic signature. In addition, noise may cause nor-
mal patients to have one or more beats with energy at high frequencies, but it is
improbable that the median four beats will include these outliers. And so, the pro-
gram generates a time-frequency decomposition of a prototypical beat, representative
of a patient's physiologic condition.
3.4 Band Aggregation
As a final step, the sixteen frequency bands are combined into four frequency bands,
spanning 50-150 Hz, 150-350 Hz, 350-550 Hz, and 550-850 Hz. The bands are
aggregated in such a way that energy at lower frequencies does not drown out higher
frequency content, i.e. higher frequency bands are weighted more heavily [22]. Thus,
we have a four-band frequency decomposition of a prototypical beat for a patient.
28
Chapter 4
Prototypical Beat Analysis
Previous work by Z. Syed describes the construction of a prototypical beat from audio
and EKG data [22]. Syed's analysis of the prototypical beat is detailed in Section
7.1. This chapter outlines our analysis of the prototypical beat. First, we begin
with the topic of normal cardiac event detection and discuss the method of locating
normal cardiac events in a prototypical beat. The following section elucidates the
feature selection process, which generates a feature set to be used later in the decision
mechanism.
4.1 Normal Cardiac Event Detection
After constructing a prototypical beat for a given patient, our program must identify
the following normal cardiac events as reference points: R-wave position, peak of S1
position, beginning of S1, end of S1, peak of S2 position, beginning of S2 and end of
S2 sound. These events are calculated in the baseband and serve as reference times in
the higher frequency bands. We also calculate a floor value for each frequency band
of the prototypical beat.
Let Zi be the one-dimensional array containing the time-frequency content of a
prototypical beat in the i-th frequency band. Specifically, Z1 , Z2 , Z3 and Z4 correspond
to content in the 50-150 Hz, 150-350 Hz, 350-550 Hz, and 550-850 Hz frequency
bands, respectively.
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As described in Section 3.3, the prototypical beat was constructed by lining up
the selected beats in time. Specifically, the R-wave in the EKG signal associated with
each beat was indexed at 4410 samples. We consider this point, i.e. the peak R-wave
of the QRS complex, as the proposed onset of systole in our prototypical beat. We
label this point q.
Next, the peak of the S1 sound is chosen by searching, in the baseband, for the
position of the maximum amplitude in a window 100 ms before to 150 ms after the
onset of the QRS complex. That is,
slpeakpos = maxpos [Z 1(q - 100 ms : q + 150 ms)]
and s1peakamp is the associated amplitude.
Now, designating the position of the S2 peak requires some backtracking. From
the original audio signal, we calculate the median S2 peak position of the selected
beats. We call this value m. After doing so, we search a 1600 sample window centered
at this median value. So,
s2peakpos = maxpos [Zl(m - 800: m + 800)]
and, similarly, s2peakamp is the corresponding amplitude.
At this point, the floor value for each band is computed. We do so by, first, dividing
systole (as defined in Section 2.1.2) into ten equal intervals and, then, averaging the
points in each interval.
systoliclength = s2peakpos - q
intervaLavgij = avg [Zi(q + j * systolic ength : q + (j + 1) * systolidength
The floor value is determined as the minimum of the ten averages.
floorvali = min [intervaLavgi,o , interval-avgi,1 , ... , intervaLavgj,9 ]
The next defined reference point is the end of the S1 sound. This is designated
as the first point to the right of the S1 peak where the baseband component hits the
band's floor value.
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slend = minpos [Zl(slpeakpos : slpeakpos + systolidength) < floorvali]
If no such point exists within the first third of systole, the program, by default,
marks the farthest right point, in the same window, where the data is below 20% of
the peak Si amplitude as the end of S1.
slend = maxpos [Zl(slpeakpos : s1peakpos + 3?J'*o'icienfth) < 0.2 s1peakamp]
In contrast, the beginning of the S1 sound is defined to be concurrent with the
R-wave of the associated EKG signal. This is because, physiologically, we know that
the onset of the QRS complex precedes S1 by an instant, as mentioned in Section
2.1.2. Furthermore, we have previously defined this point for the prototypical beat
and labeled it "q".
Finally, the S2 sound must be isolated in a similar fashion. The first points to the
left and right of the S2 peak where the data hits the floor value mark the bounds of S2.
And if no left bound is found within a window of one third of systole before the peak
S2 sound or if no such bound exists to the right, then the bounds are established at
20% of peak S2 magnitude. These points are labeled s2begin and s2end, respectively.1
Figure 4-1 illustrates the above result of detecting normal cardiac events. The
solid yellow line indicates the peak of the S1 sound in the baseband (slpeakpos). The
dotted yellow lines mark the bounds of the S1 sound. Likewise, the solid red line
represents the peak of the S2 sound, with the dotted red lines marking the edges.
The horizontal green line represents the floor value for each band. Notice that the
dotted lines representing slend, s2begin, and s2end are found to be at the points
where the signal hits the floor value in the base band. By contrast, Figure 4-2 shows
an example where the signal does not hit the floor within the first third of systole
and, therefore, the default 20% is used to mark the end of S1. Also, the figures show
that the demarcation of S1 and S2, as found in the baseband, is directly extended
to the higher frequency bands. The significance of doing so is apparent in Figure
4-3, which corresponds to an MVP patient. By using the baseband to determine the
'Later modifications to the system look for a dip in S2 in the baseband and redefines the beginning
of S2 to be at that point if the dip is sufficiently low (i.e. below 1.5 times the baseband floor value).
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Figure 4-1: S1, S2, and Floor Value Demarcation in a Prototypical Beat
bounds of S2, it is evident that much of the high frequency content visible in bands
2,3, and 4 is not due to harmonics associated with the S2 sound but rather mitral
regurgitation.
4.2 Feature Selection
Having defined the above reference points, our program now generates a feature
set, characterizing systolic activity in a prototypical beat. Specifically, the pro-
gram calculates the following features: peakmagk, peakonsetk, peakdurk, peakslopek,
peaktobandenergyk, peaktoslenergyk, peaktos2energyk, sltobandenergyi, s2tobandenergyi,
s1width and s2width; where i E {1,2,3,4}, k e {2,3,4}. The following section defines
these features and details the derivation of each. In order to make valid comparisons
between patient files, the calculation of many features includes a normalization step.
As discussed in Section 2.3.1, the acoustic signature of Mitral Valve Prolapse
consists of energy at higher frequencies during the second half of systole. Therefore,
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Figure 4-3: Si, S2, and Floor Value Demarcation with High-frequency Content
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we begin by searching for a peak between the midpoint of systole to the beginning of
S2 in each of the three higher frequency bands. The position of this peak is defined
as follows,
peakposk = maxpos [Zk(q + sy*2tiden : s2begin)]
2
and the related amplitude is called peakampk.2
The first feature, peakmagk, describes the magnitude of the mid-systolic peak
with respect to the floor value of that band. Specifically,
k = peakampyk
peakmagk foorvalk
We hypothesize that the mid-systolic peak is the crest of the murmur caused by
MVP. Consequently, we proceed to search for the beginning and end of the murmur.
We define the bounds to be the first points to the left and right of the peak where
the signal is below 25% of the peak magnitude. If the signal does not go below the
25% level, the end of Si and the beginning of S2 are set as the default ends of the
murmur. 3
peakbegink = maxpos [Zk(slend : peakposk) < 0.25 peakampk]
peakendk = minpos [Zk(peakposk : s2begin) < 0.25 peakampk]
Figures 4-4 and 4-5 illustrate how the program searches for a late-systolic peak, as
indicated by the solid magenta line, in each of the three higher frequency bands. The
dotted magenta lines mark the bounds associated with this peak, while the horizontal
cyan line represents the 25% threshold used to determine the bounds. In addition,
the figures demonstrate the differing results produced by the program when processed
over files corresponding to a physiologically normal subject versus an MVP sufferer.
The feature, peakonsetk, determines the onset of the proposed murmur in the
cardiac cycle.
2If the position of the peak is found to be concurrent with the beginning of S2, the program backs
off 10 ms and re-searches for a peak in systole.
3If the 25% value is less than the band's floor value, then the floor value is used to mark the ends
of the murmur instead.
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peakonsetk = peakceginksystolidength
In addition, two other features, peakdurk and peakslopek, are calculated using
the bounds of the murmur. The former quantifies the duration of the murmur with
respect to systolic length. The second estimates the ascending slope of the murmur,
using the peak point and the point found as the start of the murmur. As mentioned
in Section 2.3.1, murmurs associated with MVP exhibit specific morphologies. And
so, we attempt to quantify the shape of the murmur using the feature, peakslopek.
peakdurk = peakendk-peakbegink
systoliclength
peakslopek = peakampk-Z k(peakbegink)peakposk-peakbegink
Next, our program computes the energy of the murmur with respect to three dif-
ferent cardiac events. First, the energy of the murmur is calculated as a fraction of the
total energy in the related frequency band. We call this feature peaktobandenergyk.
Second, the murmur's energy is found with respect to the energy associated with S1
in each band (peaktoslenergyk). Finally, the energy of the murmur is derived as a
fraction of the energy of S2 (peaktos2energyk).
peaktobandenergyk = sum[Zk(peakbegink:peakendk)Sum[Zk]
eakt gy= sum[Zk(peakbegink:peakendk)]peaftosenergYk = msum[Zk(slbegin:slend)
g = sumZA(peakbegink:peakendk)]peaktos2energYk = sum[Zk(s2begin:s2end)]
Having collected a set of features describing systolic activity, our program proceeds
to compute statistics about other cardiac events. Now including the baseband (Z1),
the energy associated with the S1 sound in each band is calculated as a fraction of
the total energy in the frequency band. The bounds of S1 remain constant across
the frequency bands and are given by the beginning and end times of S1 found in
the baseband. This feature is labeled sltobandenergyi. Similarly, the relative energy
associated with S2 is calculated for each band (s2tobandenergyi).
sltobandenergyj = sum[Zi(s1begin:slend)]soanenegy 1 sum[Zi ]
s2tobandenergyj = sum[Z 1(s2begin:s2end)]soaneergySUM[Zi]
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Lastly, two final features, slwidth and s2width, describe the duration of the S1
and S2 sounds with respect to systolic length.
slwidth = slend-slbegin
systoliclength
s2width = s2end-s2begin
systolidength
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Chapter 5
Classification
After compiling a feature set describing a patient's cardiac activity, our final step is
to make a diagnosis based on the information. Specifically, we use an off-the-shelf,
radial kernel Support Vector Machine as a binary classifier [11]. We start with a brief
overview of support vector machines, followed by a discussion of our dataset and our
testing methodology.
5.1 Support Vector Machines
The support vector method is a recently developed technique designed for efficient
multi-dimensional function approximation [3]. The basic idea of support vector ma-
chines (SVMs) is to determine a classifier that minimizes the empirical risk, i.e. the
training set error, and the confidence interval (corresponding to the generalization,
or test set, error). Effectively, the method tries to find a hyperplane that separates
the multi-dimensional data perfectly into two classes.
In SVMs, the idea is to fix the empirical risk associated with a kernel's architec-
ture and, then, to use a method to minimize the generalization error. The primary
advantage of SVMs as adaptive models for binary classification is that they provide
a classifier with minimal Vapnik-Chervonenkis (VC) dimension, which implies low
expected probability of generalization errors [3].
In using the support vector method, it is important to consider the following
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issues. First, an appropriate architecture, or model type, must be selected according
to the sample space. Otherwise, even with zero empirical risk, it is possible to have
a large generalization error. Next, to avoid over-fitting, it is necessary to minimize
the VC dimension of the model when training on large, high-dimensional datasets.
However, in doing so, we sacrifice some margin of empirical risk. A final concern
is determining the parameters of our learning algorithm. Such parameters include
generalization and kernel parameters.
SVMs can be used to classify linearly separable data and nonlinearly separable
data, depending on the kernel function. The kernel function refers to the formula
used to calculate an inner-product in some feature space. A radial basis function
automatically determines centers, weights and thresholds that minimize an upper-
bound on the expected generalization error, drawing non-linear boundaries in the
multi-dimensional feature space [3].
After experimenting with our dataset, we determine that our problem is well-
suited to using a radial-kernel support vector machine as a binary classifier, where
each of the features calculated in Section 4.2 are used to create a multi-dimensional
feature space.
5.2 Data
This work is made possible through the efforts of our collaborators at Massachusetts
General Hospital. In particular, Dr. Francesca Nesta collected data, using an elec-
tronic stethoscope, from patients referred for echocardiograms. In addition, data was
gathered from families with one or more members diagnosed with MVP. The data
collected from the latter group was recorded on-site, in the homes of the subjects.
This is significant to understanding the poor quality-control environment in which
the data was collected.
More specifically, our dataset consists of simultaneously-recorded audio and EKG
signals for fifty-one patients. Of these patients, seventeen suffer from Mitral Valve
Prolapse, and the remaining thirty-four have normal heart sounds or benign murmurs.
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For each patient, multiple recordings were taken at different sites on the body, in
different positions. In general, we find the audio signal taken from the apical region
of the heart with the patient lying down on his/her left side to contain the most
diagnostic information, as confirmed by Dr. Nesta. Other recorded sites and positions
include the second intercostal space with the patient sitting, squatting and lying on
his/her left side.
Finally, in evaluating the performance of our system, it is important to note
two other aspects of our dataset. First, many of our non-MVP test subjects were
originally referred for an echocardiogram by their primary care physicians. That
is, an early diagnosis flagged them as potentially having MVP. The significance of
this is that a correct negative classification of any of these files is an improvement
on the performance by the primary-care physicians. Another important point to
consider in evaluating our system is that all files were labeled according to the re-
sults of an echocardiogram examination. Echocardiograms are widely considered the
gold-standard for diagnosing MVP. Therefore, we trust these labels and compare our
system's results in relation to them.
All data was sampled at 44.1 kHz with 16-bit quantization. Each data file is
approximately 30 seconds long. In addition, all data is de-identified with files assigned
labels of the form CxxSxx (where xeK).
5.3 Testing Methodology
To test the performance of our system, we use a leave-one-out cross-validation scheme.
For each patient, we train the SVM on the other 50 patients' files to create a test
model. The model is then used as the basis for classifying the given patient. Therefore,
we generate 51 different test models, one corresponding to each patient.
As mentioned, our dataset consists of 51 patients with multiple files for each.
Through experimentation with each MVP patient's data, we decide upon a "best" file,
which corresponds to the file with the most diagnostic information. For physiologically
normal patients or those with benign murmurs, we include all files associated with
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the patient. We choose this selection of files as our test set to ensure that every MVP
sample point contains physiological evidence of MVP and, therefore, representative
features of the condition. In order for the SVM to create an accurate model from its
training set, each sample point must be indicative of its corresponding classification.
Therefore, we include only a single file per MVP patient while admitting all files of a
non-MVP patient.
We then proceed to classify each patient, on a per-patient basis using his/her
file set, as suffering from MVP or not. More precisely, after the SVM conducts a
binary classification of each file associated with a patient, our program aggregates
the results of the patient's files and positively classifies the patient if any of his/her
files were considered to exhibit MVP characteristics. Therefore, we justify including
a solitary file per MVP patient because only one of the patient's files needs to be
positively classified to correctly classify the patient. In contrast, correct classification
of non-MVP subjects requires accurate classification of all the corresponding files.
Finally, through experimentation, parameters for the SVM are optimized to ob-
tain the best results. In general, we find the SVM to be surprisingly insensitive to
parameter changes. Specifically, we examined different values of the parameter C and
gamma. The parameter C controls the trade-off between training error and margin,
where lower values signify greater tolerance of training error and, therefore, better
generalization [12]. Establishing an upper bound on C prevents over-fitting of the
model. The parameter gamma relates to the radial-basis kernel function. Testing
values of C from 1 to 1000 and values of gamma from 0.1 to 2, results show minimal
variation in performance over a wide range of parameter settings. Best results were
achieved with values of C from 10-1000 and gamma from 0.8-1.8. We select C=1000
and gamma= 1.0 as a representative configuration of the SVM classifier for the rest
of this study.
42
Chapter 6
Evaluation
This chapter presents the results obtained by our system. We begin with a quantita-
tive assessment of the detector's performance on a per-patient basis. This is followed
by a qualitative analysis of our program, as revealed by the visual feature set and the
SVM models that were generated. Also, in this chapter, we compare the performance
of our classification system to Syed's system.
6.1 Quantitative Performance
As discussed in Section 5.3, we conducted leave-one-out cross-validation tests for
51 patients. Of the 51 patients, we incorrectly classified eight patients, three false
negatives and five false positives. A false negative corresponds to the misclassification
of an MVP patient. On the other hand, a false positive signifies that at least one of
the files associated with a normal (or benign) subject is incorrectly classified. And
so, the patient is falsely flagged as an MVP candidate.
Our false positive rate of approximately 15% is a significant improvement from
the previously quoted 87% found in some primary-care settings. Of the five false
positives we obtained, we found that four of the patients suffer from benign murmurs
with trace or mild regurgitation. And the prototypical beats of these patients show
a non-trivial systolic murmur such as that seen in Figure 6-1. We consider these
patients to be acceptable false positives as they exhibit significant, abnormal cardiac
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Figure 6-1: Example of False-Positive with a Benign Murmur
activity and merit further examination of their condition. Also, we believe that with
more samples of early-systolic benign murmurs such as that found in Figure 6-1, the
SVM will be better able to distinguish between MVP and benign murmurs.
Our remaining false positive corresponds to the file in Figure 6-2. This file (and
therefore patient) is incorrectly classified because harmonics associated with S2 at
higher frequencies are left-shifted, occurring prior to the dominant harmonics of S2
in the baseband. Consequently, our system considers the high-frequency energy as
part of an MVP murmur. We consider this an anomalous case.
Of more serious consequence, our system fails to correctly classify three cases of
MVP. In these cases, the telling murmur occurs so closely to S2 that our system
fails to distinguish it from the second heart sound. This could be a reflection of real
physiological circumstances, where MVP murmurs of brief duration occur just prior
to S2. Alternatively, in constructing the prototypical beat, the algorithm may have
blurred some of the information due to varying beat lengths. Figure 6-3 illustrates the
difficulty of one such case. See Appendix A for details on the other false negatives.
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Also, refer to Tables A.1 and A.2 in Appendix A for individual results obtained per
patient.
Sensitivity Specificity False Negative False Positive
Overall Results: 82% 85% 1 3 5
Table 6.1: Summary of Overall Results
6.2 Qualitative Analysis
In Syed's work, classification was based on the timing of the murmur in the three
frequency bands spanning 150-350 Hz, 350-550 Hz, and 550-850 Hz. As discussed in
Section 2.3.1, murmurs associated with Mitral Valve Prolapse have a unique acoustic
signature with many well-documented characteristics. In order to make more thor-
ough use of this medical information, we generate a fuller feature set to better capture
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Figure 6-3: Example of False-Negative File
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Figure 6-4: Example of Succinct MVP Murmur
the qualities of the murmur. This section discusses the performance of our system in
characterizing cardiac activity associated with Mitral Valve Prolapse.
Among our system's contributions, our work measures the intensity of the mur-
mur by calculating its associated energy. In doing so, we better equate MVP-related
murmurs of varying morphology. For example, loud, click-type murmurs and rela-
tively quiet, persistent murmurs report comparable energy measurements, and both
are indicative of MVP. Compare, for instance, the energy of the murmur found in
Figure 6-4 to that found in Figure 6-5.
Now, expanding on Syed's description of timing, we calculate features designating
the onset, peak and duration of the murmur. This is particularly relevant to charac-
terizing holo-systolic murmurs such as that found in Figure 6-5. Here, it is evident
that our system is capable of capturing the entire murmur.
Finally, we include features to gauge the energy and duration of the S1 and S2
sounds, as medical information suggests that Mitral Valve Prolapse may cause an
unusually quiet S1 and/or a widely split S2 sound. Figure 6-6 demonstrates one
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Figure 6-5: Example of Holo-systolic MVP Murmur
such case of MVP where the S1 sound is uncommonly muted in comparison to other
cardiac activity.
6.3 Performance Comparison to Previous System
In the figures found in this chapter, the dashed, vertical cyan lines indicate the points
that are used by Syed's system to classify the same file.' While the difference in quan-
titative performance is marginal, closer examination of the results reveals important
differences between the two systems. The following section details these differences.
First, Syed's approach is better able to handle cases where MVP murmurs occur
very close to the second heart sound. In the false-negative example shown in Figure
6-3, Syed's program captures part of the narrow murmur occurring just prior to S2
and correctly classifies the file.
Yet, in Figure 6-4, consider the dashed cyan lines in the 350-550 Hz and 550-850
'Refer to Related Work Section 7.1 for details on Syed and Curtis's classification system.
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Figure 6-6: Example of Quiet S1 Sound in MVP File
Hz frequency bands. In these bands, Syed's system misses the evident murmur by
simply using the points, demarcated by the cyan lines, to classify the file. Fortunately,
Syed's system catches the murmur in the 150-350 Hz frequency band and ultimately
classifies the file correctly. However, this case demonstrates the potential loss of
information that Syed's approach risks.
Also, in Figure 6-6, it is possible that Syed's system correctly classifies the file
for the wrong reason. That is, Syed's system misses the low amplitude, persistent,
late-systolic murmur and classifies the file based on the location of the dashed cyan
lines. This point may indeed be part of a sharp murmur immediately preceding
S2. However, Syed's program may instead be catching part of an S2 harmonic and
considering it an MVP murmur. More importantly, Syed's program fails to identify
the more apparent MVP murmur in the file. This suggests that Syed's system is
using the wrong feature to correctly classify the file while our system more accurately
delimits the murmur as shown by the dashed magenta lines.
Finally, Syed's system is more susceptible to false-positives because it does not
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Figure 6-7: Example of Corrected False Positive
consider variability in duration of S2 among subjects. As detailed in Section 7.1,
classification is based on a comparison in timing of the maximum amplitude of the
baseband in the latter half of systole and the location of the dashed cyan lines.
By only considering a single point of S2, Syed's program is prone to flagging early
harmonics associated with S2 as MVP murmurs, and therefore misclassifies some
normal patients. In contrast, our system first demarcates the bounds of S2 in the
baseband and then proceeds to search for a peak outside of that range in the upper
frequency bands. Figure 6-7 illustrates one such example where our system correctly
classifies the normal patient but Syed's reports a false positive.
6.4 Per Dimension Analysis
Although each of our features is based on physiological knowledge of MVP murmurs,
we found some features to be more critical and formative to the classification process.
Employing an SVM approach to classification enables us to use a high-dimension
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feature space, yet we lose some transparency as a consequence. In order to gain a
better understanding of the decision mechanism, we produce plots of sample points
along each dimension. A radial-kernel SVM undoubtedly combines these dimensions
and formulates decision boundaries in a complex manner, but our hypothesis is that
certain dimensions show distinct clustering of negative and positive sample points,
suggesting that the corresponding feature is a strong indicator of Mitral Valve Pro-
lapse.
Figure 6-8 plots the values obtained for the feature corresponding to the duration
of the murmur in the 350-550 Hz frequency band. The red points represent MVP
patients and the green points represent non-MVP patients. As can be seen, the graph
suggests that murmurs of duration less than 5% of systolic length indicate normal or
benign conditions. Conversely, murmurs of longer duration are a strong indicator of
Mitral Valve Prolapse. However, it is important to note that this feature, alone, is an
imperfect indicator as there are non-MVP points occurring above the 0.05 value and
MVP points present below. Nonetheless, the graph exhibits fairly strong clustering
of MVP and non-MVP sample points along this dimension.
By contrast, Figure 6-9 shows a similar plot for the feature describing the slope of
the murmur found in the 350-550 Hz frequency band. Along this dimension, values
of MVP and non-MVP files do not show any real separation. Such a plot suggests
that the feature is not a strong indicator of MVP and is, therefore, not as germane
to classification as the other features.
Refer to Appendix B.1 for equivalent plots of remaining features. While defini-
tive statements on the significance of specific features are not possible, a qualitative
analysis of the plots lends some insight into the matter. Verification of findings is
conceivable by omitting irrelevant features and evaluating the performance of new
SVM models.
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Chapter 7
Related Work
7.1 Z. Syed and D. Curtis
As previously mentioned, Zeeshan Syed created an automated auscultation system
to detect Mitral Valve Prolapse [22]. In that system, Syed first builds a prototypical
beat and then, based on this "average beat", he uses a decision mechanism to classify
patients based on band-specific time thresholds. For a given beat, in each of the three
higher frequency bands (i.e. 150-350, 350-550, 550-850 Hz), the program searches
for the earliest maximal point in the latter half of systole. The time of this position is
then normalized by dividing by the beat's systolic length. Next, if this point occurs
sufficiently prior to time of S2 in the base band (i.e., 50-150 Hz), then it is concluded
that this peak in energy is due to MVP and not S2. If any of the three bands passes
this criterion, then the beat and the patient are classified as having MVP.
In subsequent related work, Dorothy Curtis analyzed some potential algorithm re-
finements. This work looked at several time-based threshold conditions. The leftmost
time in the latter half of systole of 60%, 70%, 80%, and 100% of the maximum am-
plitude in each of the three upper bands was considered. The time of this maximum
was compared to the time of S2 in the baseband and to the time of the maximum
amplitude in the baseband. (The point of maximum amplitude in the latter half of
systole in the baseband was not necessarily co-incident with S2 in the baseband.) The
best combination found compared the time of the earliest occurrence of 60% of the
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maximum in an upper band 1 to time of the maximum value in the baseband in the
latter half of systole. This resulted in 0 false negatives and 6 false positives out of 50
patients.
While effective, Syed and Curtis's use of the time-based feature of normalized
peak-offsets omits much of the information present in the data. Most importantly,
information about the MVP murmur, including morphology, duration and volume, is
not reflected in such a feature set. As discussed extensively in Section 6.3, Syed and
Curtis's system better handles some MVP cases, but its limited feature set is prone
to false positives and speculation on the legitimacy of certain MVP classifications.
7.2 W.R. Thompson et al.
In a related study, Thompson et al. designed a system for automatically detecting
systolic murmurs due to a variety of conditions and examined the correlation between
relative murmur intensity and likelihood of pathology [24]. Cardiac auscultatory
examinations of 194 children and young adults are recorded, digitized, and stored
along with corresponding echocardiographic diagnoses. Automated spectral analysis
using continuous wavelet transforms is performed on each subject's data. Patients
without heart disease and either no murmur or an innocent murmur are compared
to patients with a variety of cardiac diagnoses and a pathologic systolic murmur
present at the left upper sternal border. The reported sensitivity and specificity of
the automated system for detecting pathologic murmurs with an intensity grade of 2
or higher are both 96%, and for grade 3+ murmurs they are 100%.
A major difference between our system and Thompson et al.'s is the specificity
of pathology. We focus on detecting Mitral Valve Prolapse, where Thompson et al.'s
system seeks to detect the general category of pathological murmurs. Due to the
difference in problem definition, Thompson et al. system does not need to identify
distinguishing features between pathologies. Instead, a spectral analysis searching
'The location of this 60% value in each upper frequency band is denoted by the dashed, vertical
cyan lines in the figures of Chapter 6.
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for irregular energy levels suffices. In addition, Thompson et al.'s test subjects are
children and young adults, concentrating on pediatric patients as opposed to the
general population. In contrast, our system aims to detect MVP, using distinctive
acoustic features, in an adult population.
7.3 C.G. DeGroff et al.
The aim of the study by DeGroff et al. was to train an artificial neural network
(ANN) to distinguish between innocent and pathological murmurs effectively [7]. Us-
ing an electronic stethoscope (frequency range, 40 to 600 Hz) and a personal computer
(sampling at 44 kHz), heart sounds are recorded from 69 patients (37 pathological
and 32 innocent murmurs). Two heart sound recordings for each patient of approx-
imately 8 heart cycles in length are recorded. Subsequently, one sound sample of
3 representative consecutive heart cycles is chosen from these 2 recordings by one
of the investigators for all 69 patients. The investigator chooses the optimal sound
sample by listening to the entirety of the 2 recordings and qualitatively determining
the sound sample (of 3 consecutive heart cycles) with the least amount of extraneous
noise, such as breathing, talking, motion artifact, and room noises. This optimal
sound sample is then processed using digital signal analysis.
A normalized energy spectrum of the sound data is obtained by applying a Fast
Fourier Transform to the heart sounds. Various spectral resolutions (1, 3, and 5 Hz)
and frequency ranges (0 to 90, 0 to 150, 0 to 210, 0 to 255, and 0 to 300 Hz) are used
as input into the ANN to optimize these parameters to obtain the most favorable
results. In this study, 100% sensitivity and specificity are obtained for the ANN
distinguishing between the 69 innocent and pathological heart murmurs presented to
it using a spectral resolution of 1 Hz and a spectrum of 0 to 210 Hz. DeGroff et al.
employ a leave-one-out cross-validation scheme for testing the 69 patient files.
A major limitation of DeGroff et al.'s system is the manual selection of optimal
beats to be analyzed. Also, the system has not yet been tested with the addition of
noise factors and, therefore, requires relatively optimal recording conditions. And, in
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contrast to our system, DeGroff et al.'s work aims to distinguish between innocent and
pathological murmurs, yet does nothing to differentiate between varying pathologies.
Lastly, the system developed by DeGroff et al. does not consider murmurs that occur
at frequencies above 300 Hz, whereas our system accounts for frequency content up
to 850 Hz.
7.4 T.R. Reed et al.
In this study, Reed et al. developed a heart sound analysis system to differentiate
between heart pathologies, based on a wavelet decomposition of the sounds and a
neural network-based classifier [19]. Heart sounds (sampled at an 8kHz sample rate,
16 bits/sample) are first hand segmented into 4096 sample segments, each consisting
of a single heartbeat cycle. Each segment is transformed using a 7-level wavelet
decomposition, based on a Coifman 4th order wavelet kernel. The resulting transform
vectors, 4096 values in length, are reduced to 256 element feature vectors by discarding
the 4 levels with shortest scale. In addition to substantially simplifying the neural
network in the classifier that follows, this step also reduces noise. The magnitudes
of the remaining coefficients in each vector are calculated, then normalized by the
vector's energy. Finally, each feature vector is classified using a three layer neural
network (256 input nodes, 50 hidden nodes, and 5 output nodes).
The system was evaluated using heart sounds corresponding to five different heart
conditions: normal, mitral valve prolapse (MVP), coarctation of the aorta (CA),
ventricular septal defect (VSD), and pulmonary stenosis (PS). The classifier was
trained using 10 shifted versions (over a range of 100 samples) of a single heartbeat
cycle from each type. The system was then presented heart sounds with varying
degrees of additive noise for classification. Because the sample set available for this
study was small, (one patient per heart condition, four heartbeat cycles per patient)
the heartbeats used in generating the shifted training exemplars were also used as
part of the basis for the evaluation set. Using this dataset, Reed et al. report 100%
accuracy in classification.
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As in DeGroff et al.'s work, Reed et al. rely on manual segmentation of the audio
file for each patient, instead of an automated approach to segmentation such as that
found in our system. Also due to the limited dataset and the overlap of the training
and test set, the evaluation of the system is incomprehensive.
7.5 I. El-Naqa et al.
In this study, El-Naqa et al. proposed the use of a support vector machine for detec-
tion of micro-calcification (MC) clusters in digital mammograms, comparing SVMs to
other existing techniques [9]. Also, El-Naqa et al. examined parameter optimization
of the SVM model in their work. In the proposed method, an SVM classifier is trained
through supervised learning to test at every location in a mammogram whether an
MC is present or not. The dataset includes 76 clinical mammograms. Disjoint sub-
sets of 38 images each are used as the training set and the test set. The SVM is
trained on the 547 MC examples present in the training set as well as 1094 MC-
absent examples. El-Naqa et al. use free-response receiver operating characteristic
curves to evaluate detection performance, and compare the proposed algorithm with
several existing methods. More specifically, performance of the SVM is compared to
the following four methods of MC detection: image difference technique, difference-
of-Gaussian method, wavelet-decomposition (WD)-based method, and a two-stage
multi-layer neural network method. These methods are representative of two main
approaches that are widely used: template-matching techniques and learning-based
methods. The WD method and the neural networks are both learning-based. Exper-
imental results demonstrate that the SVM approach yields the best performance of
the different classifiers. In particular, a sensitivity as high as 94% is achieved by the
SVM method at an error rate of one false-positive cluster per image.
In El-Naqa et al.'s study, the ability of the SVM to outperform several well-
known methods suggests that the support vector method is a promising technique
for detection in medical applications. Also of relevance to our study, El-Naqa et al.'s
results show that their proposed framework is very insensitive to the choice of model
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parameters.
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Chapter 8
Summary, Future Work and
Conclusions
8.1 Future Work
Our work here provides the foundation for further research to be done in the area.
First, our feature set includes 31 features in total. However, as mentioned in
Section 6.4, some features are stronger indicators of Mitral Valve Prolapse than others.
Although the support vector method is capable of handling irrelevant features, future
work can be done to test the sensitivity of the system to specific features and perhaps
pare down the feature set. This would help decrease the VC-dimension and improve
generalization of the model.
Also, currently our system focuses on analyzing a single prototypical beat. Further
research can be done to compare results using a beat-by-beat approach. That is,
evaluation of the system's performance using the same feature extraction algorithm
and SVM classifier on a per-beat basis is a possible avenue to be pursued.
Furthermore, our research could be extended to differentiate between other patho-
logical heart murmurs. Our method of feature extraction aims to characterize systolic
activity as a whole. Therefore, it is conceivable that our feature set can be used as the
basis for further detection and differentiation of pathological murmurs, particularly
systolic murmurs. Moreover, given the proper training set and features, the SVM is
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capable of characterizing, generalizing and classifying such cases.
Finally, our end goal is to test the application in an office setting to evaluate
performance and feasibility for mass deployment.
8.2 Conclusions
In this work, we developed a software application to detect Mitral Valve Prolapse
using acoustic features. With an electronic stethoscope, audio and EKG signals are
simultaneously recorded for 51 subjects. Based on Z. Syed's algorithm, the data is
manipulated and a prototypical beat, representative of the patient's pathology, is
generated. For our work, we extract 31 features from the prototypical beat, concen-
trating on systolic activity. We then use the feature set as input to a support vector
machine, which gives a binary classification of the patient as demonstrating MVP
characteristics or not. Of the 51 patients, we report three false negatives and five
false positives.
We also demonstrated that SVMs show significant potential in their use as an
accurate diagnostic tool for the classification of heart sound data into MVP and non-
MVP classes. Furthermore, we found the SVM to be rather insensitive to parameter
setting, achieving equivalent results over a wide range of values for C and gamma.
We believe our system can become a useful tool to primary-care physicians in di-
agnosing Mitral Valve Prolapse and, more generally, in assisting cardiac auscultation.
Also, by supporting our findings with a time-frequency decomposition of a patient's
prototypical heartbeat and its relevant features, we are able to lend critical insight
into the quality of heart murmurs. Taken as a whole, our findings convey the value
of applying digital signal processing techniques to the task of cardiac auscultation.
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Appendix A
Detailed Results
The following section contains detailed information regarding the results of our sys-
tem.
A.1 Table of Results
Tables A.1 and A.2 present the results of the SVM, having trained on the best file
per MVP patient (as indicated by an asterisk next to the file name) and all the files
associated with normal and benign subjects. Recall from Section 5.3 that correct
classification of an MVP patient requires only a single file in his/her file set to be
detected of MVP, whereas normal and benign subjects require all associated files to
be accurately classified.
A.2 False Negative Figures
Figures A-1 and A-2 correspond to the remaining two false negatives reported by our
system. Two files were processed for each of these patients. The figures contain the
prototypical beats generated for each.
First, file C36S5 exhibits a similar murmur to that found in false-negative file
C73S11, discussed in Section 6.1. The problematic MVP murmur is narrow and
occurs just prior to the second heart sound. Consequently, the system fails to identify
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Files Per Patient Correct MVP Correct non-MVP False Negative
U U U U
False Positive
Normal
C2980, C29S1 X
C37S0, C3781 X
C2180, C21S1 X
C35S25, C35826 X
C63S21 X
C63S25, C63S26 X
C63S9, C63S10 X
C74S0, C74S1 X
C1381b, C13S0 X
C35S33, C35S34 X
C37S8, C37S9 X
Benign
C3786 X
C70S3 X
C22SO X
C24S1, C2480 X
C35S18,C35S17 X
C3585,C35S4 X
C20S1, C20SO X
C1581,C1580 X
C1781,C17SO X
C2983, C2984 X
C25S2, C2580 X
C3381, C3380 X
C63S5, C6386 X
C4681, C4680 X
C63814, C63S15 X
C2781, C2780 X
C6981,C6980 X
C3480, C34S1 X
C35S31, C35S30 X
C31S2,C3180 X
C80S1, C80S2 X
C86S1, C86S2 X
Total: 29 5
Table A.1: Table of Results for Normal and Benign Subjects
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Flies Per Patient Correct MVP Correct non-MVP False Negative False Positive
MVP *:= best file
C23S1 X
C28S0 X
C67S1 X
C68S1 X
C19S1 X
C22S3 X
C28S3 X
C30SO X
C32SO X
C42S0 X
C36S5,C36S6* X
C46S2,C46S4* X
C47S1* X
C63S0 X
C73S1 1, C73S1 2* X
C85S1 X
C65S0 X
Total: 14 1 31
Table A.2: Table of Results for MVP patients
the peak in energy as independent of S2. Subsequent modifications to the system to
account for the case included searching for a secondary peak within the S2 bounds
in the upper frequency bands. Three new features, describing the location of the
secondary peaks with respect to the location of the peak of S2, were computed and
presented to the SVM. Even so, the SVM failed to classify C36S5 correctly. However,
this may be due to the lack of training samples with murmurs of a similar type.
More data is required to make a definitive statement on the effectiveness of the code
modifications. File C36S6 corresponds to the same patient as file C36S5, and our
system has difficulty identifying the murmur as separate from S2 in this file as well.
Our last false-negative is shown in Figure A-2. In the files of this patient, the
energy of the murmur with respect to other cardiac events is too small for the SVM to
classify them as MVP. Notice that the program does identify a murmur in file C46S2.
Later work attempted to capture trends between frequency bands by calculating
interband energy ratios. However, these new features did not improve quantitative
results. Collecting more samples of similar murmurs may be beneficial here as well.
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C36S5
C36S6
Figure A-1: False-Negative I
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C46S2
C46S4
Figure A-2: False-Negative II
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Appendix B
Supplementary Figures
The following section contains supplementary information previously related in this
work.
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